Inhibition of MEK/ERK1/2 signalling alters endothelial nitric oxide synthase activity in an agonist-dependent manner.
about
Pin1 prolyl isomerase regulates endothelial nitric oxide synthaseEndothelial caveolar subcellular domain regulation of endothelial nitric oxide synthaseDifferential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptorsNitric oxide inhibits ACTH-induced cortisol production in near-term, long-term hypoxic ovine fetal adrenocortical cellsThe mechanism of (R,R) ZX-5 on increasing NO releaseEphrin-A1 is up-regulated by hypoxia in cancer cells and promotes angiogenesis of HUVECs through a coordinated cross-talk with eNOS.The Neuroprotective Effect of Lithium in cannabinoid Dependence is Mediated through Modulation of Cyclic AMP, ERK1/2 and GSK-3β Phosphorylation in Cerebellar Granular Neurons of RatVascular endothelial growth factor acts through novel, pregnancy-enhanced receptor signalling pathways to stimulate endothelial nitric oxide synthase activity in uterine artery endothelial cells.Phytoestrogen genistein up-regulates endothelial nitric oxide synthase expression via activation of cAMP response element-binding protein in human aortic endothelial cells.ADP signaling in vascular endothelial cells: ADP-dependent activation of the endothelial isoform of nitric-oxide synthase requires the expression but not the kinase activity of AMP-activated protein kinase.Extracellular signal-regulated kinases 1/2 signaling pathways are not involved in endothelin regulation of mouse inner medullary collecting duct nitric oxide production.Adrenocorticotropic Hormone and PI3K/Akt Inhibition Reduce eNOS Phosphorylation and Increase Cortisol Biosynthesis in Long-Term Hypoxic Ovine Fetal Adrenal Cortical Cells.Absence of the calcium-binding protein, S100A1, confers pulmonary hypertension in mice associated with endothelial dysfunction and apoptosis.
P2860
Q24617827-8833D0CB-ACD7-4E3A-B8ED-BBD56CEE9D7BQ27009407-8528C9EF-6E99-44AA-88BD-197A2F6E7A1BQ33695494-20664C97-AB59-4A3F-9B60-2F00873B2255Q34146027-B880E679-5D54-43BD-9FF6-A51DDFB9FA35Q34205628-383B59D3-26C2-4D50-B027-260CFD06A870Q34990038-75DA1F4B-8AA1-4353-98AC-4C357CAE5738Q36358395-0C101DC6-33E6-479F-BC38-E7879DA56C23Q37188408-A35D5FE7-26EF-46AE-8136-EBB14FEADF99Q37217586-8B9C618B-C9CB-449F-A20B-336895BF20B3Q37431885-F772AFC8-3EFB-4B5B-BBAA-FDF461861779Q37498823-8F850DDC-F733-4035-8D41-7185E220DB3BQ41472144-1DD5F2B1-B2D5-4DBC-929A-A26BF6704E8BQ42468514-9024B127-945E-428F-A1B6-41E0AA7D24FE
P2860
Inhibition of MEK/ERK1/2 signalling alters endothelial nitric oxide synthase activity in an agonist-dependent manner.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Inhibition of MEK/ERK1/2 signa ...... n an agonist-dependent manner.
@en
type
label
Inhibition of MEK/ERK1/2 signa ...... n an agonist-dependent manner.
@en
prefLabel
Inhibition of MEK/ERK1/2 signa ...... n an agonist-dependent manner.
@en
P2860
P356
P1433
P1476
Inhibition of MEK/ERK1/2 signa ...... n an agonist-dependent manner.
@en
P2093
Ian M Bird
Jacqueline M Cale
P2860
P304
P356
10.1042/BJ20060371
P407
P577
2006-09-01T00:00:00Z